论文部分内容阅读
目的探讨多肿瘤标志物联合检测对消化系统肿瘤的诊断价值,以供临床诊断参考。方法对我院收治的48例消化系统恶性肿瘤患者、97例消化系统良性疾病患者和101例在我院进行体检的健康者作为本次实验的实验对象。三组被检者均给予多肿瘤标志物CA199、CEA、CA242、AFP、CA125和CA153检测。结果消化系统恶性肿瘤患者的肿瘤标志物检测结果各值均高于其他两组患者,经统计学分析,P<0.05,差异有统计学意义。结论采用多肿瘤标志物联合检测对消化系统恶性肿瘤患者具有较好的临床价值,可用于消化系统肿瘤的普查。
Objective To investigate the diagnostic value of multi-tumor marker combined detection of digestive system tumors for clinical diagnosis. Methods Forty-eight patients with digestive system malignancy, 97 patients with benign digestive diseases and 101 healthy people who underwent physical examination in our hospital were enrolled in this study. Three groups of subjects were given multiple tumor markers CA199, CEA, CA242, AFP, CA125 and CA153 detection. Results The results of tumor marker detection in patients with digestive system malignant tumors were higher than those in the other two groups. After statistical analysis, P <0.05, the difference was statistically significant. Conclusion Combined detection of multiple tumor markers has good clinical value for patients with digestive system malignancies and can be used for the screening of digestive system tumors.